Rocket Pharmaceuticals Inc. logo

Rocket Pharmaceuticals Inc.

RCKT | NASDAQ
Chart Builder DCF Calculator
$3.27
-$0.10 (-2.97%)
At close: Sep 21, 2026, 4:00 PM ET
$3.27
$0 (0.00%)
Pre-market: Sep 22, 2026, 4:52 AM ET

Market Data

Market Cap
$367.98M
Enterprise Value
$157.35M
Beta
0.50
Average Volume
2.13M
Shares Outstanding (Diluted)
114.51M
Shares Change YoY
3.15%
Institutional Ownership
86.68%
Exchange
NASDAQ
ISIN
US77313F1066

Price Performance

Price Change 1M
-7.4%
Price Change 3M
-5.8%
Price Change 6M
-30.1%
Price Change YTD
-5.5%
Price Change 1Y
2.8%
Price Change 3Y
-84.0%
Price Change 5Y
-89.8%
1M CAGR (ann.)
-4.8%
1Y CAGR (ann.)
11.2%
5Y CAGR (ann.)
-37.5%
All-Time CAGR
-15.6%

Valuation

PE Ratio
-19.24
Forward PE
N/A
PEG Ratio
-0.14
Forward PEG
-0.02
PS Ratio
N/A
Forward PS
31.70
PB Ratio
0.97
P/FCF Ratio
-2.10
P/Adj. FCF Ratio
-1.77
P/OCF Ratio
-2.17
EV/Sales
N/A
EV/EBIT
-40.34
EV/EBITDA
19.79
EV/FCF
-0.92
Earnings Yield
-5.2%
FCF Yield
-47.7%
Adj. FCF Yield
-56.6%

Financial Health

Net Cash
$199.71M
Total Debt
$24.8M
Cash & Short-Term Investments
$224.51M
Total Assets
$423.1M
Current Ratio
9.24
Quick Ratio
9.24
Debt / Equity Ratio
0.07
Debt / EBITDA
3.12
Debt / FCF
-0.15
OCF / Debt
-6.87
Interest Coverage
-40.53
Altman Z-Score
0.25
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-18.6%

Returns

Return on Assets
-4.1%
Return on Equity
-5.8%
Return on Invested Capital
-48.5%
Return on Capital Employed
-48.9%
Return on Tangible Assets
-4.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
71.8%
EPS CAGR 5Y
27.2%
EPS CAGR 10Y
10.1%
FCF CAGR 3Y
10.3%
FCF CAGR 5Y
-1.7%
FCF CAGR 10Y
-16.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
19
EPS Growth Next 3Y
-122.9%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.39
EPS Growth Est (next Q)
-13.3%
Revenue Est (next Q)
$200K
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$9
Price Target Upside
175.2%

Cash Flow

Operating Cash Flow
$-170.28M
Free Cash Flow
$-170.4M
Adj. Free Cash Flow
$-202.19M
FCF Per Share
-$1.51
OCF Per Share
-$1.51
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-2.15M
Operating Income
$-191.64M
EBITDA
$7.95M
Net Income
$-17.25M
EPS (Diluted)
-$0.17
Revenue / Employee
N/A
Profit / Employee
$-85.4K
Employees
202

© 2026 bestshares.com. All rights reserved.